Brain Stem Neoplasms
-
Subject Areas on Research
- A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.
- A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent.
- A machine learning-based prediction model of H3K27M mutations in brainstem gliomas using conventional MRI and clinical features.
- A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.
- A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.
- ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.
- ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis.
- Aurora kinase B is a potential therapeutic target in pediatric diffuse intrinsic pontine glioma.
- Brainstem auditory evoked potential monitoring: when is change in wave V significant?
- Brainstem stereotactic biopsy sampling in children.
- Cancer. For pediatric glioma, leave no histone unturned.
- Cerebellopontine angle meningiomas: postoperative outcomes in a modern cohort.
- Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.
- Clinical characteristics and treatment of malignant brainstem gliomas in elderly patients.
- Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
- Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.
- Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
- Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.
- Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.
- Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG.
- Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.
- Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.
- Intensity-modulated stereotactic radiosurgery using dynamic micro-multileaf collimation.
- Intraaxial dermoid cyst of the medulla.
- Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study.
- Local delivery methods of therapeutic agents in the treatment of diffuse intrinsic brainstem gliomas.
- Malignant brainstem gliomas in adults: clinicopathological characteristics and prognostic factors.
- Neurophysiologic intraoperative monitoring of the glossopharyngeal and vagus nerves.
- PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
- Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma.
- Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.
- Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
- Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
- Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma.
- Preoperative evaluation of neural tracts by use of three-dimensional anisotropy contrast imaging in a patient with brainstem cavernous angioma: technical case report.
- Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.
- Surgical management of brainstem cavernomas: selection of approaches and microsurgical techniques.
- Symptomatic brainstem cavernomas.
- T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
- The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults.
- The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.
- The presigmoid approach to anterolateral pontine cavernomas. Clinical article.
-
Keywords of People
- McLendon, Roger Edwin, Professor of Pathology, Pathology